Inventor

Pramod K. Srivastava

Inventor

Riverdale, NY, US

Overview

1989–2019

Patent span

Human necessities

Primary field (CPC A)

Patents· 64 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes24%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%

Y02ATechnologies for adaptation to climate change19%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%

C07KPeptides9%

G01NInvestigating or analysing materials by determining their chemical or physical properties4%

C12NMicroorganisms or enzymes3%

A61NElectrotherapy2%

C40BCombinatorial chemistry2%

C07CAcyclic or carbocyclic compounds1%

PatentTitleYear

10,501,801Identification of tumor-protective epitopes for the treatment of cancers2019 9,566,348'Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes'2017 9,352,019'Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality'2016 9,248,172'Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality'2016 8,877,204'Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes'2014 8,591,890'Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality'2013 8,029,808'Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality'2011 7,666,581'Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease'2010 7,601,359'Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins'2009 7,449,557'Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy'2008 7,186,515'Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof'2007 7,179,462'Î± (2) macroglobulin receptor as a heat shock protein receptor and uses thereof'2007 7,132,109'Using heat shock proteins to increase immune response'2006 6,797,480'Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents'2004 6,475,490'Compositions and methods for promoting tissue repair using heat shock proteins'2002 6,468,540'Immunotherapeutic stress protein-peptide complexes against cancer'2002 6,461,615'Therapeutic and prophylactic methods using heat shock proteins'2002 6,455,048'Prevention of primary and metastatic neoplastic diseases with hsp70-peptide complexes'2002 6,455,503'Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens'2002 6,451,316'Methods for generating antigen-reactive T cells in vitro'2002 6,447,781'Therapeutic and prophylactic methods using heat shock proteins'2002 6,447,780'Prevention of primary and metastatic neoplastic diseases with hsp90-peptide complexes'2002 6,436,404'Prevention of primary and metastatic neoplastic diseases with GP96-peptide complexes'2002 6,410,028'Therapeutic and prophylactic methods using heat shock proteins'2002 6,410,027'Methods for preparation of vaccines against cancer'2002 6,410,026'Methods for preparation of vaccines against cancer'2002 6,406,700'Methods for preparation of vaccines against cancer'2002 6,403,095'Treatment of primary and metastatic neoplastic diseases with HSP70-peptide complexes'2002 6,399,069'Prevention of infectious diseases with hsp70-peptide complexes'2002 6,399,070'Methods and compositions for eliciting an immune response with hsp90-peptide complexes'2002 6,391,306'Treatment of infectious diseases with hsp90-peptide complexes'2002 6,387,374'Treatment of primary and metastatic neoplastic diseases with hsp90-peptide complexes'2002 6,383,494'Methods and composition for eliciting an immune response with gp96-peptide complexes'2002 6,383,491'Prevention of infectious diseases with hsp90-peptide complexes'2002 6,383,493'Methods and compositions for eliciting an immune response with hsp70-peptide complexes'2002 6,383,492'Treatment of infectious diseases with gp96-peptide complexes'2002 6,379,672'Prevention of infectious diseases with gp96-peptide complexes'2002 6,375,953'Treatment of infectious diseases with HSP70-peptide complexes'2002 6,322,790'Compositions and methods for eliciting an immune response using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy'2001 6,187,312'Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of infectious diseases'2001 6,168,793'Heat shock protein 70 preparations in vaccination against cancer and infectious disease'2001 6,162,436'Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of neoplastic diseases'2000 6,156,302'Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes'2000 6,143,299'Compositions and methods using complexes of heat shock protein gp96 and antigenic molecules for the treatment and prevention of infectious diseases'2000 6,139,841'Compositions and methods using complexes of heat shock protein 70 and antigenic molecules for the treatment and prevention of infectious diseases'2000 6,136,315'Compositions and methods using complexes of heat shock protein 70 and antigenic molecules for the treatment and prevention of neoplastic diseases'2000 6,130,087'Methods for generating cytotoxic T cells in vitro'2000 6,048,530'Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens'2000 6,030,618'Therapeutic and prophylactic methods using heat shock proteins'2000 6,017,540'Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes'2000 6,017,544'Composition comprising immunogenic stress protein-peptide complexes against cancer and a cytokine'2000 6,007,821'Method and compositions for the treatment of autoimmune disease using heat shock proteins'1999 5,997,873'Method of preparation of heat shock protein 70-peptide complexes'1999 5,985,270'Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes'1999 5,961,979'Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens'1999 5,948,646'Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes'1999 5,935,576'Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens'1999 5,837,251'Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases'1998 5,830,464'Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy'1998 5,750,119'Immunotherapeutic stress protein-peptide complexes against cancer'1998 4,978,782'Organic disulfide compound useful as antiradiation agents'1990 4,952,338'Unsymmetrical organic disulfide compounds useful as antiradiation agents'1990 4,943,657'Unsymmetrical organic disulfide compounds useful as antiradiation agents'1990 4,883,890'Unsymmetrical organic disulfide compounds useful as antiradiation agents'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989–1990Patents assigned to UNIV VANDERBILT (3)· patent assignee history

1989–1990Based in Varanasi, IN· patent location history

1998–2009Patents assigned to UNIV FORDHAM (38)· patent assignee history

1998–2002Patents assigned to SINAI SCHOOL MEDICINE (8)· patent assignee history

1998–2009Based in Riverdale, NY, US· patent location history

1999–2019Based in Avon, CT, US· patent location history

2001Based in New York, NY, US· patent location history

2004–2016Patents assigned to UNIV CONNECTICUT HEALTH CT (10)· patent assignee history

2013–2014Patents assigned to SRIVASTAVA PRAMOD K (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV FORDHAM	38	1998–2009
UNIV CONNECTICUT HEALTH CT	10	2004–2016
SINAI SCHOOL MEDICINE	8	1998–2002
UNIV VANDERBILT	3	1989–1990
SRIVASTAVA PRAMOD Kself	2	2013–2014

Locations

Location	Patents	Span
Riverdale, New York, US	37	1998–2009
Avon, CT, US	22	1999–2019
Varanasi, IN	4	1989–1990
New York, New York, US	1	2001